P3 Health Partners Inc [NASDAQ: PIII] traded at a high on Thursday, posting a 29.49 gain after which it closed the day’ session at $0.48.
The results of the trading session contributed to over 7251435 shares changing hands. Over the past one week, the price volatility of P3 Health Partners Inc stands at 15.88% while the volatility over the past one month is 12.06%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for PIII stock reached $77.48 million, with 116.59 million shares outstanding and 69.99 million shares in the current float. Compared to the average trading volume of 467.11K shares, PIII reached a trading volume of 7251435 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about P3 Health Partners Inc [PIII]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PIII shares is $2.47 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PIII stock is a recommendation set at 1.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BTIG Research have made an estimate for P3 Health Partners Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on April 01, 2024. While these analysts kept the previous recommendation, BTIG Research raised their target price to Buy. The new note on the price target was released on September 01, 2023, representing the official price target for P3 Health Partners Inc stock.
The Average True Range (ATR) for P3 Health Partners Inc is set at 0.05, with the Price to Sales ratio for PIII stock in the period of the last 12 months amounting to 0.06. The Price to Book ratio for the last quarter was 0.46, with the Price to Cash per share for the same quarter was set at 0.48.
How has PIII stock performed recently?
P3 Health Partners Inc [PIII] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 53.43. With this latest performance, PIII shares gained by 4.13% in over the last four-week period, additionally sinking by -4.39% over the last 6 months – not to mention a drop of -69.68% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PIII stock in for the last two-week period is set at 63.82, with the RSI for the last a single of trading hit 74.30, and the three-weeks RSI is set at 57.05 for P3 Health Partners Inc [PIII]. The present Moving Average for the last 50 days of trading for this stock 0.4602, while it was recorded at 0.3634 for the last single week of trading, and 0.7115 for the last 200 days.
P3 Health Partners Inc [PIII]: Deeper insight into the fundamentals
P3 Health Partners Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.69 and a Current Ratio set at 0.69.
Earnings analysis for P3 Health Partners Inc [PIII]
With the latest financial reports released by the company, P3 Health Partners Inc posted -0.12/share EPS, while the average EPS was predicted by analysts to be reported at -0.22/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.1. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PIII.
Insider trade positions for P3 Health Partners Inc [PIII]
There are presently around $23.63%, or 30.83%% of PIII stock, in the hands of institutional investors. The top three institutional holders of PIII stocks are: ALYESKA INVESTMENT GROUP, L.P. with ownership of 15.95 million shares, which is approximately 13.4152%. ARMISTICE CAPITAL, LLC, holding 7.9 million shares of the stock with an approximate value of $$3.56 million in PIII stocks shares; and ARMISTICE CAPITAL, LLC, currently with $$2.85 million in PIII stock with ownership which is approximately 5.3228%.
